545445-44-1Relevant articles and documents
Preparation method of apixaban intermediate suitable for industrial production
-
, (2021/08/19)
The invention discloses a synthesis method of an apixaban intermediate suitable for industrial production. The method comprises the following steps: carrying out phase-transfer catalytic amidation reaction on paranitroaniline and 5-chlorovaleryl chloride in an organic phase and water phase two-phase system under an inorganic weakly alkaline condition to obtain an APM01 solution, and adding a sodium hydroxide water solution, and cyclizing in a pot to obtain an APM02 solution; directly carrying out alpha-reactive hydrogen dichlorination on an APM02 organic solution and phosphorus pentachloride after simple acid pickling, liquid separation and drying to obtain an APM03 solution; carrying out condensation-elimination reaction on the APM03 solution and excessive morpholine after simple acid pickling and liquid separation, and carrying out simple crystallization and purification treatment to separate out an APM04 solid, and reducing the APM04 into APM05 by sodium sulfide; and carrying out amidation-cyclization two-step one-pot reaction on the APM05 and 5-chlorovaleryl chloride to prepare a key intermediate APM07. According to the method, the synthesis efficiency of the apixaban intermediate is improved, the reaction is mild, and dangerous NaH and other expensive reagents are not used, so that the production cost is saved, the operation is simple, and the method is suitable for industrial popularization.
Preparation method of 5,6-dihydropyridine-2 (1H)-one derivative
-
, (2020/06/17)
The invention provides a preparation method of a 5,6-dihydropyridine-2 (1H)-one derivative, and particularly relates to a 1-(piperidine-2-keto-1-yl)-4-(5,6-dihydro-3-R substituent pyridine-2 (1H)-keto-1-yl) benzene preparation method, wherein the R substituent is chlorine or morpholine-4-yl. According to the invention, p-acetamido aniline is used as a raw material, and amidation with delta-valerolactone, halogenation with a halogenation reagent or sulfonylation with sulfonyl chloride, condensation, deacetylation, amidation with 2,2-dichloro-delta-valerolactone, halogenation with a halogenationreagent or sulfonylation with sulfonyl chloride, condensation elimination or condensation elimination substitution in the presence of morpholine are performed to obtain the target product. Accordingto the invention, the raw materials used in the preparation method are cheap, easy to obtain and low in cost; the process operation is simple, reaction conditions are easy to realize, the wastewater yield is low, and safety and greenness are realized; and the reaction selectivity of each step is high, the product yield and purity are high, and industrial production is facilitated.
Preparation method of dihydropyridone derivatives
-
Paragraph 0059-0063; 0069; 0073-0077; 0082-0086; 0091-0095, (2020/05/30)
The invention belongs to the technical field of medicines, and particularly relates to a preparation method of dihydropyridone derivatives. The preparation method comprises the following steps: reacting 1-(4-aminophenyl)-3-morpholinyl-5,6-dihydropyridin-2(1H)-one serving as a raw material with a first reactant in a first solvent under the condition of a first alkali to generate an amide compound;under the condition of a second alkali, heating the amide compound to obtain an intermediate; reacting the intermediate with a second reactant in a second solvent at room temperature; after the reaction is finished, performing reduced-pressure distillation to obtain the second solvent; and under an ice bath condition, adding a third alkali, and carrying out a reaction in a third solvent to obtainthe dihydropyridone derivatives. According to the preparation method of the dihydropyridone derivatives provided by the invention, the preparation method of the dihydropyridone derivatives of 3-morpholinyl-1-(4-(2-oxopiperidine-1-yl)phenyl)pyridin-2(1H)-one is provided for the first time, and the preparation method has important significance for effective control of the quality of apixaban.